Head of Marketing & Communications
+1 720 471 4625
Please enter your information in the form for general inquiries or to contact sales.
Additional contact information is listed below.
You may be able to find the information you need amongst the frequently asked questions.
Acarix is a Swedish medical device company that innovates solutions for rapid rule out of coronary artery disease (CAD) at point of care.
The CE-approved and FDA DeNovo-cleared Acarix CADScor System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive, and costly diagnostic procedures.2
The CADScor System has been used on more than 29,000 patients.3 Acarix recommends CADScor System as a first-line diagnostic aid that uses highly sensitive acoustics and computational processing to analyze coronary blood flow to rule out significant coronary artery disease (CAD), with at least 96% certainty at point of care.1
Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX). Erik Penser Bank AB (+46 8 463 83 00, email@example.com) is the Certified Advisor of Acarix.